Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic Therapy
VETC+ predicts a significantly longer OS in patients with unresectable HCC treated with TKI/BEVA and can be used as surrogate marker on liver biopsy of angiogenesis-driven molecular class.
Institutions
- University of Modena and Reggio Emilia (IT)
- Humanitas University (IT)
- University of Padua (IT)
- Vita-Salute San Raffaele University (IT)
- National Taiwan University (TW)
- University of Milan (IT)
- Yonsei University (KR)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Ospedale Maggiore (IT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Istituto Oncologico Veneto (IT)
- Hôpitaux Universitaires Henri-Mondor (FR)
- National Taiwan University Hospital (TW)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- IRCCS Humanitas Research Hospital (IT)
- University of Hong Kong (HK)
Publication Details
- Journal
- Liver Cancer
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1159/000547669
- Citations
- 1
- Primary Topic
- Geochemistry and Geologic Mapping
- Type
- article
- Field-Weighted Citation Impact
- 2.48